A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1758-9193
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
A deep learning MRI approach outperforms other biomarkers of prodromal Alzheimer’s disease ; volume:14 ; number:1 ; day:29 ; month:3 ; year:2022 ; pages:1-11 ; date:12.2022
Alzheimer's research & therapy ; 14, Heft 1 (29.3.2022), 1-11, 12.2022
- Creator
-
Feng, Xinyang
Provenzano, Frank A.
Small, Scott A.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s13195-022-00985-x
- URN
-
urn:nbn:de:101:1-2022061809531512253778
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Feng, Xinyang
- Provenzano, Frank A.
- Small, Scott A.
- SpringerLink (Online service)
Other Objects (12)
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease
Biomarkers in Alzheimer’s disease
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease
Biomarkers in Alzheimer’s disease
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease
Correction to: A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
EEG biomarkers in Alzheimer’s and prodromal Alzheimer’s: a comprehensive analysis of spectral and connectivity features
Synaptic proteins in CSF as potential novel biomarkers for prognosis in prodromal Alzheimer’s disease
Brainstem substructures and cognition in prodromal Alzheimer’s disease
Cerebrospinal Fluid Biomarkers for the Diagnosis of Prodromal Alzheimer’s Disease in Amnestic Mild Cognitive Impairment
Davunetide sex-dependently boosts memory in prodromal Alzheimer’s disease
Differentiating Prodromal Dementia with Lewy Bodies from Prodromal Alzheimer’s Disease: A Pragmatic Review for Clinicians
Free Recall Outperforms Story Recall in Associations with Plasma Biomarkers in Preclinical Alzheimer Disease
Biomarkers in Alzheimer’s disease
A phase III randomized trial of gantenerumab in prodromal Alzheimer’s disease
Blood biomarkers for Alzheimer’s disease
Neuroimaging Biomarkers for Alzheimer’s Disease